Characterisation of tumour-associated antigens in colon cancer

Cancer Immunology, Immunotherapy

Volumn 51, Issue 10, 2002, Pages 574-582

  Line, Aija ^a   Slucka, Zane ^a   Stengrevics, Aivars ^b   Silina, Karina ^a   Li, Geng ^c   Rees, Robert C ^c  

^a UNIVERSITY OF LATVIA   (Latvia)

^b RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^c NOTTINGHAM TRENT UNIVERSITY   (United Kingdom)

Author keywords

AD034; Autoantibody; NAP1L1; RHAMM; SEREX

Indexed keywords

AD034 ANTIGEN; C21ORF2 ANTIGEN; COMPLEMENTARY DNA; EPRS ANTIGEN; MESSENGER RNA; NAP1L1 ANTIGEN; PROTEIN TYROSINE KINASE; RHAMM ANTIGEN; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIGEN DETECTION; ANTIGEN EXPRESSION; ANTIGEN SPECIFICITY; ARTICLE; CANCER TISSUE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DNA ISOLATION; DNA LIBRARY; DNA SEQUENCE; GENE EXPRESSION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; SEROLOGY; SERUM; TISSUE DISTRIBUTION;

ADENOCARCINOMA; ALTERNATIVE SPLICING; ANTIBODIES, NEOPLASM; ANTIGENS, CD44; ANTIGENS, NEOPLASM; CLONING, MOLECULAR; COLONIC NEOPLASMS; EXTRACELLULAR MATRIX PROTEINS; GENE LIBRARY; HUMANS; ISOANTIBODIES; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; TISSUE DISTRIBUTION;

EID: 0036035517     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-002-0322-2     Document Type: Article

References (38)

1. Abetamann V, Kern HF, Elsasser HP (1996) Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells. Clin Cancer Res 2:1607
2. Ali SA, Lynam J, McLean CS, Entwise C, Loudon P, Rojas JM, McArdle SE, Li G, Mian S, Rees RC (2002) Tumor regression induced by intratumor therapy with a disabled infectious single cycle (DISC) herpes simplex virus (HSV) vector, DISC/HSV/murine granulocyte-macrophage colony-stimulating factor, correlates with antigen-specific adaptive immunity. J Immunol 168:3512
3. Assmann V, Gillett CE, Poulsom R, Ryder K, Hart IR, Hanby AM (2001) The pattern of expression of the microtubule-binding protein RHAMM/IHABP in mammary carcinoma suggests a role in the invasive behaviour of tumour cells. J Pathol 195:191
4. Assmann V, Jenkinson D, Marshall JF, Hart IR (1999) The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments. J Cell Sci 112(22):3943
5. Assmann V, Marshall JF, Fieber C, Hofmann M, Hart IR (1998) The human hyaluronan receptor RHAMM is expressed as an intracellular protein in breast cancer cells. J Cell Sci 111(12):1685
6. Chen YT, Scanlan MJ, Sahin U, Tureci O, Gure AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ (1997) A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 94:1914
7. Cooper TA, Mattox W (1997) The regulation of splice-site selection, and its role in human disease. Am J Hum Genet 61:259
8. Duval A, Rolland S, Compoint A, Tubacher E, Iacopetta B, Thomas G, Hamelin R (2001) Evolution of instability at coding and non-coding repeat sequences in human MSI-H colorectal cancers. Hum Mol Genet 10:513
9. Hall CL, Turley EA (1995) Hyaluronan: RHAMM mediated cell locomotion and signaling in tumorigenesis. J Neurooncol 26:221
10. Hardwick C, Hoare K, Owens R, Hohn HP, Hook M, Moore D, Cripps V, Austen L, Nance DM, Turley EA (1992) Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility. J Cell Biol 117:1343
11. Hofmann M, Fieber C, Assmann V, Gottlicher M, Sleeman J, Plug R, Howells N, von Stein O, Ponta H, Herrlich P (1998) Identification of IHABP, a 95-kDa intracellular hyaluronate binding protein. J Cell Sci 111(12):1673
12. Jager D, Stockert E, Scanlan MJ, Gure AO, Jager E, Knuth A, Old LJ, Chen YT (1999) Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: Characterization of tissue-specific ING1 transcripts and a homologue gene. Cancer Res 59:6197
13. + cancers. Proc Natl Acad Sci USA 97:12198
14. Jager E, Nagata Y, Gnjatic S, Wada H, Stockert E, Karbach J, Dunbar PR, Lee SY, Jungbluth A, Jager D, Arand M, Ritter G, Cerundolo V, Dupont B, Chen YT, Old LJ, Knuth A (2000) Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses. Proc Natl Acad Sci USA 97:4760
15. Knights AJ, Zaniou A, Rees RC, Pawelec G, Müller L (2002) Prediction of an HLA-DR-binding peptide derived from Wilms' tumour 1 protein and demonstration of in vitro immunogenicity of WT1 (124-138)-pulsed dendritic cells generated according to an optimised protocol. Cancer Immunol Immunother 51:271
16. Lanzavecchia A, Lezzi G, Viola A (1999) From TCR engagement to T cell activation: A kinetic view of T cell behavior. Cell 96:1
17. Li H, Guo L, Li JW, Liu N, Qi R, Liu J (2000) Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: Relevance with tumor progression. Int J Oncol 17:927
18. Line A, Stengrevics A, Slucka Z, Li G, Jankevics E, Rees RC (2002) Serological identification and expression analysis of gastric cancer-associated genes. Br J Cancer 86:1824
19. Mashino K, Sadanaga N, Tanaka F, Yamaguchi H, Nagashima H, Inoue H, Sugimachi K, Mori M (2001) Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas. Br J Cancer 85:713
20. Mian S, Robins RA, Rees RC, Fox B (2001) Immunogenicity of tumour associated antigens: In: Robins RA, Rees RC (eds) Cancer Immunology. Kluwer Academic Publishers, Dordrecht/Boston/London, p 1
21. Pfreundschuh M (2000) Exploitation of the B cell repertoire for the identification of human tumor antigens. Cancer Chemother Pharmacol 46:S3
22. Philips AV, Cooper TA (2000) RNA processing and human disease. Cell Mol Life Sci 57:235
23. Rees RC, Pawelec G, Muller L, Robins A (2002) Progress in vaccination against cancer (PIVAC) 2001, Robinson College, University of Cambridge, UK. Cancer Immunol Immunother 51:58
24. Sahin U, Li G, Tureci O, Pfreundschuh M (2001) Recognition of human tumors: SEREX expression cloning to identify tumour antigens: In: Robins RA, Rees RC (eds) Cancer Immunology. Kluwer Academic Publishers, Dordrecht/Boston/London, p 45
25. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M (1995) Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 92:11810
26. Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD, Tureci O, Sahin U, Pfreundschuh M, Old LJ (1998) Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76:652
27. Sherman L, Sleeman J, Herrlich P, Ponta H (1994) Hyaluronate receptors: Key players in growth, differentiation, migration and tumor progression. Curr Opin Cell Biol 6:726
28. Simon HU, Mills GB, Kozlowski M, Hogg D, Branch D, Ishimi Y, Siminovitch KA (1994) Molecular characterization of hNRP, a cDNA encoding a human nucleosome-assembly-protein I-related gene product involved in the induction of cell proliferation. Biochem J 297(2):389
29. Stockert E, Jager E, Chen YT, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A, Old LJ (1998) A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 187:1349
30. Toh Y, Kuwano H, Mori M, Nicolson GL, Sugimachi K (1999) Overexpression of metastasis-associated MTA1 mRNA in invasive oesophageal carcinomas. Br J Cancer 79:1723
31. Toh Y, Oki E, Oda S, Tokunaga E, Ohno S, Maehara Y, Nicolson GL, Sugimachi K (1997) Overexpression of the MTA1 gene in gastrointestinal carcinomas: Correlation with invasion and metastasis. Int J Cancer 74:459
32. Tureci O, Sahin U, Zwick C, Neumann F, Pfreundschuh M (1999) Exploitation of the antibody repertoire of cancer patients for the identification of human tumor antigens. Hybridoma 18:23
33. Tureci O, Schmitt H, Fadle N, Pfreundschuh M, Sahin U (1997) Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 272:6416
34. Turley EA, Austen L, Moore D, Hoare K (1993) Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: Only RHAMM is essential for hyaluronan-promoted locomotion. Exp Cell Res 207:277
35. Turley EA, Austen L, Vandeligt K, Clary C (1991) Hyaluronan and a cell-associated hyaluronan binding protein regulate the locomotion of ras-transformed cells. J Cell Biol 112:1041
36. Viola A, Lanzavecchia A (1996) T cell activation determined by T cell receptor number and tunable thresholds. Science 273:104
37. Wang C, Thor AD, Moore DH, Zhao Y, Kerschmann R, Stern R, Watson PH, Turley EA (1998) The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. Clin Cancer Res 4:567
38. Yamada Y, Itano N, Narimatsu H, Kudo T, Hirohashi S, Ochiai A, Niimi A, Ueda M, Kimata K (1999) Receptor for hyaluronan-mediated motility and CD44 expressions in colon cancer assessed by quantitative analysis using real-time reverse transcriptase-polymerase chain reaction. Jpn J Cancer Res 90:987